Research Advisory Panel
California law, pursuant to Health & Safety Code Sections 11480 & 11481, requires proposed research projects involving certain opioid, stimulant, and hallucinogenic drugs classified as Schedule I and Schedule II Controlled Substances, to be reviewed and authorized by the Research Advisory Panel of California in the Attorney General’s Office. See the Guidelines page for specific criteria.
The Research Advisory Panel primarily seeks to ensure the safety and protection of participating human research subjects and adequate security of the controlled substances used in the study. The Panel Members evaluate the scientific validity of each proposed project, and may reject proposals where the research is poorly conceived, would produce conclusions of little scientific value, or would not justify the exposure of California subjects to the risk of research.
During 2007 the Panel reviewed fifty-nine new research study submissions. Fifty-three were approved by the Panel, including twenty-six Academic research studies, and twenty-seven Multicenter Clinical Drug Trial protocols. Ten of the approved studies were Substance Abuse Treatment research protocols.
At the end of 2007 the Panel was monitoring134 research projects.
Applicants may contact the Panel Office, or utilize the DEA Controlled Substance Listings link for further information on controlled substance schedules.